World-First Human Trial Offers New Type 1 Diabetes Treatment
St Vincent’s Institute of Medical Research
A commonly prescribed rheumatoid arthritis drug may suppress the progression of type 1 diabetes
Phase 1/2 trial showed the safety and therapeutic potential of administering a novel transgene
Per the WHO records, more than 39 million people were living with HIV at the end of 2022
Sign up for all of our 2024 digital events with one click
Join Today's Clinical Lab and our experts for our ID & AMR Digital Forum on July 9, 2024
Pathologists can share images and consult a network of experts to deliver timely, cost-effective patient care